These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20301040)

  • 1. [Bosenten and sildenafil in the treatment of Eisenmenger syndrome].
    Białkowski J
    Kardiol Pol; 2010 Feb; 68(2):248-9. PubMed ID: 20301040
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
    Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
    Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil.
    Molelekwa V; Akhter P; McKenna P; Bowen M; Walsh K
    Ir Med J; 2005 Mar; 98(3):87-8. PubMed ID: 15869069
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
    Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
    Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil in Eisenmenger syndrome: safety first.
    Wort SJ
    Int J Cardiol; 2007 Sep; 120(3):314-6. PubMed ID: 17477991
    [No Abstract]   [Full Text] [Related]  

  • 6. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
    Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
    J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM; Fan KY; Chow WH
    Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of Eisenmenger syndrome in the modern treatment era: a case report.
    Gatzoulis MA
    Eur Respir Rev; 2011 Dec; 20(122):293-6. PubMed ID: 22130823
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyspnea in Eisenmenger syndrome and its amelioration by sildenafil: role of J receptors.
    Anand A; Srivastava N; Barwad P; Ramakrishnan S; Roy A; Bhargava B
    Int J Cardiol; 2014 Jul; 174(3):574-8. PubMed ID: 24820738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
    Beghetti M; Galiè N
    J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist].
    Micheletti A; Butera G; Chessa M; Carminati M
    Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861
    [No Abstract]   [Full Text] [Related]  

  • 14. A multiple combined treatment in an adult patient with Eisenmenger's syndrome.
    Grutter G; Guccione P; Mantione L; Giannico S; Parisi F; Di Donato R; Pongiglione G
    Int J Cardiol; 2011 Sep; 151(3):372-3. PubMed ID: 21757244
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome.
    Mohammed S; Vijayvergiya R; Malhotra S; Rohit MK
    Indian Heart J; 2021; 73(5):633-636. PubMed ID: 34627582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil use in patients with the Eisenmenger syndrome.
    Rosenthal E
    Circulation; 2004 Apr; 109(16):e197; author reply e197. PubMed ID: 15117867
    [No Abstract]   [Full Text] [Related]  

  • 17. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sildenafil on survival of patients with Eisenmenger syndrome.
    Sun YJ; Yang T; Zeng WJ; Gu Q; Ni XH; Zhao ZH; Liu ZH; Xiong CM; He JG
    J Clin Pharmacol; 2013 Jun; 53(6):611-8. PubMed ID: 23553708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
    Iversen K; Jensen AS; Jensen TV; Vejlstrup NG; Søndergaard L
    Eur Heart J; 2010 May; 31(9):1124-31. PubMed ID: 20202971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.
    Hall SM; Davie N; Klein N; Haworth SG
    Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.